DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/xffzmh/drug_delivery_in)
has announced the addition of Jain PharmaBiotech s new report "Drug
Delivery in Central Nervous System Diseases - Technologies, Markets and
Companies" to their offering.
Advances in understanding of the cell biology of the BBB have opened new
avenues and possibilities for improved drug delivery to the CNS. Buy Urispas (Flavoxate) without prescription Several
carrier or transport systems, enzymes, and receptors that control the
penetration of molecules have been identified in the BBB endothelium. About Cleocin (Clindamycin) with free prescription
Receptor-mediated transcytosis can transport peptides and proteins
across the BBB. Benemid (Probenecid) with free prescription Methods are available to assess the BBB permeability of
drugs at the discovery stage to avoid development of drugs that fail to
reach their target site of action in the CNS.
Many of the new developments in the treatment of neurological disorders
will be biological therapies and these will require innovative methods
for delivery. About Estrace without Rx Cell, gene and antisense therapies are not only innovative
treatments for CNS disorders but also involve sophisticated delivery
methods. About Pamelor (Nortriptyline) RNA interference (RNAi) as a form of antisense therapy is also
described.
The role of drug delivery is depicted in the background of various
therapies for neurological diseases including drugs in development and
the role of special delivery preparations. Buy Body Lotion online Pain is included as it is
considered to be a neurological disorder. http://anti-infectives-opinion.blogspot.com A special chapter is devoted
to drug delivery for brain tumors. Cell and gene therapies will play an
important role in the treatment of neurological disorders in the future.
The method of delivery of a drug to the CNS has an impact on the drug s
commercial potential. The market for CNS drug delivery technologies is
directly linked to the CNS drug market. Values are calculated for the
total CNS market and the share of drug delivery technologies. Starting
with the market values for the year 2014, projections are made to the
years 2019 and 2024. The markets values are tabulated according to
therapeutic areas, technologies and geographical areas. Unmet needs for
further development in CNS drug delivery technologies are identified
according to the important methods of delivery of therapeutic substances
to the CNS. Finally suggestions are made for strategies to expand CNS
delivery markets. Besides development of new products, these include
application of innovative methods of delivery to older drugs to improve
their action and extend their patent life.
Profiles of 76 companies involved in drug delivery for CNS disorders are
presented along with their technologies, products and 80 collaborations.
These include pharmaceutical companies that develop CNS drugs and
biotechnology companies that provide technologies for drug delivery. A
number of cell and gene therapy companies with products in development
for CNS disorders are included. References contains over 420
publications that are cited in the report. The report is supplemented
with 51 tables and 12 figures.
Key Topics Covered:
Executive Summary
1. Basics of Drug Delivery to the Central Nervous System
2. Blood Brain Barrier
3. Methods of Drug Delivery to the CNS
4. Delivery of Cell, Gene and Antisense Therapies to the CNS
5. Drug Delivery for Treatment of Neurological Disorders
6. Drug delivery for brain tumors
7. Markets for Drug Delivery in CNS Disorders
8. Companies
9. References
For more information visit .researchandmarkets.com/research/xffzmh/drug_delivery_in
Source: Jain PharmaBiotech
No comments:
Post a Comment